	Despesas De Vendas E Administração		Data
AbbVie	USD 3.89B	325M	2025-12
Amgen	USD 1.94B	237M	2025-12
Anika Therapeutics	USD 12.91M	17.8M	2025-03
Arrowhead Research	USD 46.02M	8.84M	2025-12
AstraZeneca	USD 148M	4.86B	2025-09
BioCryst Pharmaceuticals	USD 80.47M	15.39M	2024-12
Biogen	USD 545.2M	38.6M	2025-09
Bristol-Myers Squibb	USD 2.18B	392M	2025-12
Enanta Pharmaceuticals	USD -1.05	0.31	2024-12
Gilead Sciences	USD 1.35B	6M	2025-09
GlaxoSmithKline	GBP 2.68B	518M	2025-12
Halozyme Therapeutics	USD 37.53M	4.53M	2025-09
Heron Therapeutics	USD 23.34M	4.18M	2024-09
Immunic	USD -0.24	0.03	2024-09
Incyte	USD 390.41M	61.33M	2025-12
Insmed	USD 186.38M	109.94M	2025-09
Ionis Pharmaceuticals	USD 86.56M	4.04M	2025-09
J&J	USD 6.75B	831M	2025-12
Karyopharm Therapeutics	USD 27.19M	442K	2024-12
Ligand Pharmaceuticals	USD 28.45M	8.27M	2025-09
Merck	USD 2.85B	215M	2025-12
Neurocrine Biosciences	USD 291.6M	5.3M	2025-09
Novartis	USD 3.31B	134M	2025-09
Novavax	USD 66.95M	34.05M	2024-09
Pfizer	USD 4.08B	894M	2025-12
PTC Therapeutics	USD 84.05M	1.22M	2025-09
Roche Holding	CHF 7.28B	3.99B	2025-12
Sarepta Therapeutics	USD 77.11M	7.22M	2025-09
Vertex Pharmaceuticals	USD 445.1M	20.5M	2025-09

Enanta Pharmaceuticals Despesas De Vendas E Administração - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.